Cargando…
Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
Adult T-cell leukemia-lymphoma is a distinct type of peripheral T-cell lymphoma caused by human T-cell lymphotropic virus type I. Although allogeneic stem cell transplantation after chemotherapy is a recommended treatment option for patients with aggressive adult T-cell leukemia-lymphoma, there is n...
Autores principales: | Fuji, Shigeo, Yamaguchi, Takuhiro, Inoue, Yoshitaka, Utsunomiya, Atae, Moriuchi, Yukiyoshi, Uchimaru, Kaoru, Owatari, Satsuki, Miyagi, Takashi, Taguchi, Jun, Choi, Ilseung, Otsuka, Eiichi, Nakachi, Sawako, Yamamoto, Hisashi, Kurosawa, Saiko, Tobinai, Kensei, Fukuda, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566038/ https://www.ncbi.nlm.nih.gov/pubmed/28341734 http://dx.doi.org/10.3324/haematol.2017.164996 |
Ejemplares similares
-
Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
por: Makita, Shinichi, et al.
Publicado: (2019) -
Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results
por: Utsunomiya, Atae, et al.
Publicado: (2022) -
Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
por: Nakano, Kazumi, et al.
Publicado: (2014) -
The oncogenic driving force of CD30 signaling‐induced chromosomal instability in adult T‐cell leukemia/lymphoma
por: Nakashima, Makoto, et al.
Publicado: (2023) -
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020)